These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 35992788)

  • 21. Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma.
    Zhang C; Zhou D; Wang Z; Ju Z; He J; Zhao G; Wang R
    Front Genet; 2022; 13():907754. PubMed ID: 35754819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 23. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
    Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
    Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
    Zhong S; Chen S; Lin H; Luo Y; He J
    BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma.
    Wang X; Jing H; Li H
    Transl Lung Cancer Res; 2023 Feb; 12(2):230-246. PubMed ID: 36895935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Analysis of Molecular Clusters and Prognostic Signature Based on m7G-related LncRNAs in Esophageal Squamous Cell Carcinoma.
    Zhao F; Dong Z; Li Y; Liu S; Guo P; Zhang D; Li S
    Front Oncol; 2022; 12():893186. PubMed ID: 35912250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer.
    Li Z; Zhao J; Huang X; Wang J
    Sci Rep; 2023 Mar; 13(1):4302. PubMed ID: 36922569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
    Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
    Front Genet; 2022; 13():903117. PubMed ID: 35692827
    [No Abstract]   [Full Text] [Related]  

  • 31. Three molecular subtypes and a five-gene signature for hepatocellular carcinoma based on m7G-related classification.
    Yue Y; Tao J; An D; Shi L
    J Gene Med; 2024 Jan; 26(1):e3611. PubMed ID: 37847055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma.
    Xia F; Yan Y; Shen C
    Front Cell Dev Biol; 2021; 9():811734. PubMed ID: 34966747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma.
    Li Y; Zhao K; Wu R; Wang J; Wang Q; Xiong Q; Xie F; Lei H; Feng P
    J Gastrointest Oncol; 2023 Jun; 14(3):1392-1411. PubMed ID: 37435203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma.
    Zhou K; Yang J; Li X; Xiong W; Zhang P; Zhang X
    Front Surg; 2022; 9():893977. PubMed ID: 35784919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression characteristics of long non-coding RNA in colon adenocarcinoma and its potential value for judging the survival and prognosis of patients: bioinformatics analysis based on The Cancer Genome Atlas database.
    Li R; Gao X; Sun H; Sun L; Hu X
    J Gastrointest Oncol; 2022 Jun; 13(3):1178-1187. PubMed ID: 35837189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.
    Peng YL; Dong YF; Guo LL; Li MY; Liao H; Li RS
    PLoS One; 2023; 18(8):e0289552. PubMed ID: 37535570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma.
    Wang H; Shui X; Zhang Z; He M; Tai S; Lin Y
    Transl Cancer Res; 2024 Jun; 13(6):2799-2811. PubMed ID: 38988942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A signature of five 7-methylguanosine-related genes is a prognostic marker for lung squamous cell carcinoma.
    Liu W; Wang Y; Ulivi P; Tavolari S; Rizvi SAA; Capobianco E; Navarro A; Zhang Y
    J Thorac Dis; 2023 Nov; 15(11):6265-6278. PubMed ID: 38090319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.